Phase II Study of Doxorubicin and Avastin® in Sarcoma.
Clinical trial NCT00755261 · TERMINATED
Trial details
- NCT number
- NCT00755261
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-09-01
- Primary completion
- 2010-09-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.